It is increasingly recognized that humans and other animals are multi-organismal, comprising co-evolved animal cells and microbial cells. The implications are profound. For example, interactions with pathogens are just a small subset of the diversity of animal-microbial interactions, and human health can only be understood fully in the context of the resident microbiota. This growing appreciation of the ubiquity and importance of beneficial microbes is both contributing to, and builds on, remarkable advances in our capacity to determine the diversity and function of complex microbial communities, especially through advanced sequencing methods. The impacts of this research include a re-evaluation of the nature of animal-microbial interactions and immense opportunities for novel therapies to promote human health. The 2014 Beneficial Microbes Conference will provide a forum for the exchange of the latest conceptual and technological developments in this fast-moving field. It will provide an overview of the current state of research and future directions of inquiry, achieved by bringing together US and international researchers from multiple disciplines (microbiology, immunology, genomics, nutrition, ecology, systems biology, evolutionary biology and clinical science) who study a diversity of associations. Core sponsorship has generously been provided by The American Society for Microbiology (ASM), and the meeting will be held in Washington DC on 27-30 September, 2014. The meeting has five sessions: (1) Beneficial Microbes in Human Health and Disease, to identify the causal roles of microbiota in promoting health and influencing susceptibility to disease (2) Evolutionary Dynamics of Host-Microbe Interactions, especially how coevolution among microbes and between host µbes can shape host-microbial interactions;(3) Diet and Immune Function: Cross-Species Perspectives, will investigate the role of diet (both nutrition and pre/probiotic formulations) in regulating immunological function, in humans, biomedical models and other systems;(4) The Ecology of Host-Microbial Interactions will apply principles of population ecology and community ecology to explain and predict the composition and function of host-associated microbial communities;and (5) Microbiota and the Gut-Brain Axis will explore the impact of microbiota on brain function and behavior, including feeding, activity and indices of """"""""mood"""""""". Each session will include two invited talks, four talks selected from submitted abstracts, and a further talk (invited or selected) per session with a quantitative flavor, to disseminate best practice in analysis of large datasets and facilitate discussion of outstanding barriers to computational analysis and mathematical modeling of host-microbial interactions. The conference will include advertised opportunities for break-out groups to discuss specific topics, and a Conference Discussion on Future Directions in Beneficial Microbes Research, which will be the foundation for a published commentary on research priorities to overcome current barriers to advancement of the field. Invitations and travel funds will ensure that early-career researchers, women and minorities are well-represented among speakers and all participants.

Public Health Relevance

Human health is dependent on interactions with coevolved, resident microorganisms that inhabit the gut, skin and other surfaces of our bodies. These beneficial microbes have profound effects on all aspects of human physiology, from nutrition and metabolism to immune function and, by extrapolation from animal studies, possibly fertility and behavior. The central importance of interactions with resident microorganisms is transforming the research agenda of biologists and biomedical scientists, with opportunities for revolutionary new therapeutic interventions against various chronic diseases. The 2014 Beneficial Microbes Conference is sponsored by The American Society for Microbiology, with the aim of this conference is to provide a forum for discussion and exchange of ideas, and for the development of new approaches and a conceptual synthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Conference (R13)
Project #
1R13GM112396-01
Application #
8785711
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Sledjeski, Darren D
Project Start
2014-09-01
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
American Society for Microbiology
Department
Type
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20036